N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0144100 |
| CAS No | NA |
| Mol.F. | C23H25N9O3 |
| Mol.Wt. | 475.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144101 |
| CAS No | NA |
| Mol.F. | C27H31ClN8O3 |
| Mol.Wt. | 551.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144102 |
| CAS No | NA |
| Mol.F. | C27H31ClN8O3 |
| Mol.Wt. | 551.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144103 |
| CAS No | NA |
| Mol.F. | C27H31ClN8O3 |
| Mol.Wt. | 551.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144104 |
| CAS No | NA |
| Mol.F. | C24H23N7O3 |
| Mol.Wt. | 457.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144105 |
| CAS No | NA |
| Mol.F. | C28H34N8O4 |
| Mol.Wt. | 546.63 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144106 |
| CAS No | NA |
| Mol.F. | C31H34N8O4 |
| Mol.Wt. | 582.67 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144107 |
| CAS No | NA |
| Mol.F. | C23H19FN6O3 |
| Mol.Wt. | 446.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144108 |
| CAS No | 856842-33-6 |
| Mol.F. | C10H12N4O2 |
| Mol.Wt. | 220.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144109 |
| CAS No | NA |
| Mol.F. | C16H18N4O2 |
| Mol.Wt. | 298.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144110 |
| CAS No | 79917-37-6 |
| Mol.F. | C5H4N2O |
| Mol.Wt. | 108.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144111 |
| CAS No | NA |
| Mol.F. | C13H10N4O5S2 |
| Mol.Wt. | 366.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144112 |
| CAS No | NA |
| Mol.F. | C8H5ClN2O6S2 |
| Mol.Wt. | 324.71 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144113 |
| CAS No | NA |
| Mol.F. | C9H9ClN2O7S2 |
| Mol.Wt. | 356.75 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144114 |
| CAS No | NA |
| Mol.F. | C13H9ClN4O6S2 |
| Mol.Wt. | 416.81 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144115 |
| CAS No | NA |
| Mol.F. | C7H5N3O4 |
| Mol.Wt. | 195.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |